HRP20030077B1 - NOVEL alpha CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT - Google Patents

NOVEL alpha CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT

Info

Publication number
HRP20030077B1
HRP20030077B1 HR20030077A HRP20030077A HRP20030077B1 HR P20030077 B1 HRP20030077 B1 HR P20030077B1 HR 20030077 A HR20030077 A HR 20030077A HR P20030077 A HRP20030077 A HR P20030077A HR P20030077 B1 HRP20030077 B1 HR P20030077B1
Authority
HR
Croatia
Prior art keywords
crystalline form
preparation
pharmaceutical preparations
preparations containing
butylamine salt
Prior art date
Application number
HR20030077A
Other languages
English (en)
Croatian (hr)
Inventor
Pfeiffer Bruno
Ginot Yves-Michel
Coquerel G�rard
Beilles St�phane
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8852172&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20030077(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of HRP20030077A2 publication Critical patent/HRP20030077A2/hr
Publication of HRP20030077B1 publication Critical patent/HRP20030077B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/022—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2
    • C07K5/0222—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -X-C(=O)-(C)n-N-C-C(=O)-Y-; X and Y being heteroatoms; n being 1 or 2 with the first amino acid being heterocyclic, e.g. Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
HR20030077A 2000-07-06 2003-02-06 NOVEL alpha CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT HRP20030077B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0008793A FR2811320B1 (fr) 2000-07-06 2000-07-06 Nouvelle forme cristalline alpha du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
PCT/FR2001/002167 WO2001087835A1 (fr) 2000-07-06 2001-07-06 FORME CRISTALLINE α DU SEL DE TERT-BUTYLAMINE DU PERINDOPRIL

Publications (2)

Publication Number Publication Date
HRP20030077A2 HRP20030077A2 (en) 2003-04-30
HRP20030077B1 true HRP20030077B1 (en) 2011-07-31

Family

ID=8852172

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20030077A HRP20030077B1 (en) 2000-07-06 2003-02-06 NOVEL alpha CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT

Country Status (35)

Country Link
US (2) US20030186896A1 (bg)
EP (1) EP1296947B1 (bg)
JP (2) JP3602826B2 (bg)
KR (1) KR100513570B1 (bg)
CN (1) CN1328259C (bg)
AP (1) AP1537A (bg)
AR (1) AR034124A1 (bg)
AT (1) ATE258918T1 (bg)
AU (2) AU7641801A (bg)
BG (1) BG64868B1 (bg)
BR (1) BR0112367A (bg)
CA (1) CA2415438C (bg)
CZ (1) CZ297672B6 (bg)
DE (1) DE60101968T2 (bg)
DK (1) DK1296947T3 (bg)
EA (1) EA005008B1 (bg)
EE (1) EE05268B1 (bg)
ES (1) ES2214434T3 (bg)
FR (1) FR2811320B1 (bg)
GE (1) GEP20043361B (bg)
HK (1) HK1055425A1 (bg)
HR (1) HRP20030077B1 (bg)
ME (1) ME00443B (bg)
MX (1) MXPA02012949A (bg)
NO (1) NO323447B1 (bg)
NZ (1) NZ523173A (bg)
OA (1) OA12304A (bg)
PL (1) PL206359B1 (bg)
PT (1) PT1296947E (bg)
RS (1) RS50915B (bg)
SK (1) SK285714B6 (bg)
TR (1) TR200400238T4 (bg)
UA (1) UA57188C2 (bg)
WO (1) WO2001087835A1 (bg)
ZA (1) ZA200210092B (bg)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2838648B1 (fr) * 2002-04-18 2004-05-21 Servier Lab Nouveau sel de perindopril et les compositions pharmaceutiques qui le contiennent
GB2395195A (en) 2002-11-18 2004-05-19 Cipla Ltd Preparation of perindopril from carboxy-protected precursor, & perindopril monohydrates for use as angiotensin converting enzyme (ACE) inhibitors
SI1636185T1 (sl) * 2003-06-24 2012-06-29 Servier Lab Nove kristaliniäśne oblike perindopril erbumina
ES2336554T3 (es) 2003-10-21 2010-04-14 Les Laboratoires Servier Nuevo metodo para la preparacion de perindopril erbumina cristalina.
SI21703A (en) 2004-01-14 2005-08-31 Lek Farmacevtska Druzba Dd Inclusion complexes of perindopril, procedure of their preparation, pharmaceutical compositions containing these complexes and their application in treatment of hypertensia
ES2603856T3 (es) * 2004-03-29 2017-03-01 Les Laboratoires Servier Procedimiento para preparar una composición farmacéutica sólida
US20050250706A1 (en) * 2004-05-07 2005-11-10 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
WO2005108365A1 (en) * 2004-05-07 2005-11-17 Glenmark Pharmaceuticals Limited Processes for the preparation of alpha polymorph of perindopril erbumine
SI21800A (sl) * 2004-05-14 2005-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nov postopek sinteze perindoprila
SI21881A (sl) 2004-10-15 2006-04-30 Diagen, Smartno Pri Ljubljani, D.O.O. Nove kristalne oblike perindopril erbumin hidratov, postopek za njihovo pripravo in farmacevtske oblike, ki vsebujejo te spojine
SG125976A1 (en) * 2005-03-11 2006-10-30 Servier Lab New gama crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
SG125975A1 (en) * 2005-03-11 2006-10-30 Servier Lab New alpha crystalline form of perindopril tert-butylamine salt, a process for its preparation and pharmaceutical compositions containing it
JP2006290825A (ja) * 2005-04-13 2006-10-26 Shiono Chemical Co Ltd アルファ型ペリンドプリルエルブミンの製造法
WO2007017894A2 (en) * 2005-05-05 2007-02-15 Arch Pharmalabs Limited PREPARATION OF NOVEL CRYSTALLINE η(ETA) FORM OF PERINDOPRIL ERBUMINE
US20070032661A1 (en) * 2005-08-03 2007-02-08 Glenmark Pharmaceuticals Limited Process for the preparation of intermediates of perindopril
MX2008002066A (es) * 2005-08-12 2008-04-16 Sandoz Ag Neuva forma cristalina de perindopril-erbumina.
US20100016614A1 (en) * 2005-08-12 2010-01-21 Lek Pharmaceuticals D.D Process for the preparation of perindopril erbumine
EP1815857A1 (en) 2006-02-02 2007-08-08 LEK Pharmaceuticals D.D. A pharmaceutical composition comprising perindopril
WO2007092758A2 (en) * 2006-02-03 2007-08-16 Dr. Reddy's Laboratories Ltd. Crystalline forms of perindopril erbumine
FR2897866B1 (fr) * 2006-02-28 2008-04-18 Servier Lab Forme cristalline alpha du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
FR2897865B1 (fr) 2006-02-28 2008-04-18 Servier Lab Forme cristalline beta du sel d'arginine du perindopril, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
EA200600630A1 (ru) * 2006-04-20 2007-02-27 ИСМАГИЛОВ, Искандар Халиуллович ζ-ЗЕТА ФОРМА ПЕРИНДОПРИЛ ЭРБУМИНА
EP1964836A3 (en) * 2006-11-06 2008-11-19 IPCA Laboratories Limited A process for the preparation of perindopril erbumine in alpha crystalline form
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
EP2137148A1 (en) * 2007-03-22 2009-12-30 Aarti Healthcare Limited Process for the preparation of perindopril erbumine salt and novel polymorph (s) thereof
WO2008120241A2 (en) * 2007-03-29 2008-10-09 Ipca Laboratories Limited Novel alcohol solvates of perindopril erbumine
SI22543A (sl) 2007-06-27 2008-12-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Nove soli perindoprila
AU2013201812B2 (en) * 2007-06-27 2015-04-02 Les Laboratoires Servier Salts of perindopril
SI23149A (sl) 2009-09-21 2011-03-31 Silverstone Pharma Nove benzatinske soli ACE inhibitorjev, postopek za njihovo pripravo in njihova uporaba za zdravljenje kardiovaskularnih bolezni
PT105315B (pt) * 2010-09-29 2013-01-16 Inst Superior Tecnico Uma nova forma cristalina hidratada de erbumina de perindopril, métodos para a sua preparação e sua utilização em preparações farmacêuticas
CN103822996A (zh) * 2014-03-20 2014-05-28 东英（江苏）药业有限公司 一种培哚普利叔丁胺盐含量的测定方法
CN105395497B (zh) * 2015-12-04 2019-06-18 杭州新诺华医药有限公司 一种稳定的α晶型培哚普利叔丁胺片及制备方法
EP3842035A1 (en) 2019-12-23 2021-06-30 KRKA, d.d., Novo mesto Composition for the preparation of perindopril arginine granules, a method for their preparation and pharmaceutical composition comprising the granules

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049658A1 (fr) * 1980-10-02 1982-04-14 Adir Iminodiacides substitués, leur préparation et compositions pharmaceutiques les contenant
EP0308339A1 (fr) * 1987-09-17 1989-03-22 Adir Et Compagnie Procédé de synthèse industrielle de l'acide perhydroindole carboxylique - 2 (2S, 3aS, 7aS). Application à la synthèse de carboxyalkyl dipeptides
EP0308341A1 (fr) * 1987-09-17 1989-03-22 Adir Et Compagnie Procédé de synthèse industrielle du périndopril et de ses principaux intermédiaires de synthèse

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2620744A1 (fr) * 1987-09-17 1989-03-24 Degremont Procede de traitement par l'ozone de materiaux ligno-cellulosiques, notamment de pates a papier et reacteur pour la mise en oeuvre de ce procede
FR2771010B1 (fr) * 1997-11-19 2003-08-15 Adir Utilisation d'une combinaison d'un inhibiteur de l'enzyme de conversion de l'angiotensine et d'un diuretique pour le traitement des desordres microcirculatoires
FR2811318B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline gamma du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent
FR2811319B1 (fr) * 2000-07-06 2002-08-23 Adir Nouvelle forme cristalline beta du sel de tert-butylamine du perindopril, son procede de preparation et les compositions pharmaceutiques qui la contiennent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0049658A1 (fr) * 1980-10-02 1982-04-14 Adir Iminodiacides substitués, leur préparation et compositions pharmaceutiques les contenant
EP0308339A1 (fr) * 1987-09-17 1989-03-22 Adir Et Compagnie Procédé de synthèse industrielle de l'acide perhydroindole carboxylique - 2 (2S, 3aS, 7aS). Application à la synthèse de carboxyalkyl dipeptides
EP0308341A1 (fr) * 1987-09-17 1989-03-22 Adir Et Compagnie Procédé de synthèse industrielle du périndopril et de ses principaux intermédiaires de synthèse

Also Published As

Publication number Publication date
JP5016185B2 (ja) 2012-09-05
ZA200210092B (en) 2003-12-12
PL348492A1 (en) 2002-01-14
DE60101968D1 (de) 2004-03-11
NO20030024L (no) 2003-01-03
ATE258918T1 (de) 2004-02-15
EP1296947A1 (fr) 2003-04-02
EE200300001A (et) 2004-08-16
OA12304A (en) 2003-12-29
ES2214434T3 (es) 2004-09-16
TR200400238T4 (tr) 2004-03-22
WO2001087835A1 (fr) 2001-11-22
KR20030024773A (ko) 2003-03-26
UA57188C2 (uk) 2003-06-16
EP1296947B1 (fr) 2004-02-04
AR034124A1 (es) 2004-02-04
CZ297672B6 (cs) 2007-02-28
EA200300107A1 (ru) 2003-06-26
CN1328259C (zh) 2007-07-25
AU2001276418B2 (en) 2005-07-28
SK1492003A3 (en) 2003-06-03
AP1537A (en) 2006-01-10
BR0112367A (pt) 2003-05-13
KR100513570B1 (ko) 2005-09-09
SK285714B6 (sk) 2007-06-07
BG64868B1 (bg) 2006-07-31
PL206359B1 (pl) 2010-07-30
HK1055425A1 (en) 2004-01-09
GEP20043361B (en) 2004-06-10
US20030186896A1 (en) 2003-10-02
EE05268B1 (et) 2010-02-15
YU100402A (sh) 2003-08-29
CA2415438A1 (fr) 2001-11-22
NZ523173A (en) 2004-04-30
AU7641801A (en) 2001-11-26
CA2415438C (fr) 2009-01-20
NO20030024D0 (no) 2003-01-03
RS50915B (sr) 2010-08-31
FR2811320A1 (fr) 2002-01-11
MXPA02012949A (es) 2003-05-15
JP3602826B2 (ja) 2004-12-15
US20050059609A1 (en) 2005-03-17
CZ2003357A3 (cs) 2003-05-14
ME00443B (me) 2011-10-10
DK1296947T3 (da) 2004-06-01
EA005008B1 (ru) 2004-10-28
JP2003533507A (ja) 2003-11-11
CN1440387A (zh) 2003-09-03
PT1296947E (pt) 2004-05-31
AP2002002691A0 (en) 2002-12-31
BG107532A (bg) 2003-12-31
FR2811320B1 (fr) 2002-08-23
NO323447B1 (no) 2007-05-07
JP2005047902A (ja) 2005-02-24
DE60101968T2 (de) 2004-12-23
HRP20030077A2 (en) 2003-04-30

Similar Documents

Publication Publication Date Title
HRP20030077B1 (en) NOVEL alpha CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL PREPARATIONS CONTAINING IT
HRP20060361A2 (en) Novel c-crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same
AP1452A (en) Novel y crystalline form of perindopril tert-butylamine salt preparation method, and pharmaceutical compositions containing same.
TW200736197A (en) New crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
MA28451B1 (fr) Nouvelle forme cristalline v de l'agomelatine, son procede de preparation et les compositions pharmaceutiques qui la contiennent
MY148319A (en) New crystalline form vi of agomelatine, a process for its preparation and pharmaceutical compositions containing it
BRPI0713010A2 (pt) compostos para o tratamento de doença periodontal
CA2508824A1 (fr) Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
RS51541B (sr) 5-hloro-3-(4-metansulfonilfenil)-6'-metil-/2,3'/bipiridinil u čistom kristalnom obliku i postupak sinteze
SG154333A1 (en) The use of substituted cyanopyrrolidines and combination preparations containing them for treating hyperlipidemia and associated diseases
GEP20043365B (en) Polymorphic Salt
ES8306371A1 (es) "un procedimiento para la preparacion de sales de s-adenosilmetionina".
BR0206730A (pt) Processo para preparar uma composição de valproato de sódio não-higroscópica, composição farmacêutica não-higroscópia e seu uso
UA66866C2 (uk) Синтез морфолінових похідних
HUT72090A (en) Positive inotropic and lusitropic pyrroloquinolinone derivatives, pharmaceutical compositions containing them and process for their production
BR9815292A (pt) Cristal de derivado de despsipeptìdeo e método para a sua produção
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
NO20001541L (no) Nye substituerte dimeriske forbindelser, fremgangsmÕte for deres fremstilling og farmasøytiske sammensetninger inneholdende dem
Dann et al. A Framework Containing Ga‐O‐Ga Links: The Synthesis and Structure of Gallobicchulite Ca8 (Ga2SiO6) 4 (OH) 8
MA28191A1 (fr) Nouvelle forme cristalline "alpha" du sel de tert -butylamine du perindoprill, son procede de preparation et les compositions pharmaceutiques qui la contiennent.
BR0215002A (pt) Métodos de preparação de inibidores de permutadores de sódio-hidrogênio de tipo 1
NO993608D0 (no) Nye 8H-tieno-[2,3-b]pyrrolizin-8-on forbindelser, fremgangsmåte ved deres fremstilling og farmasoeytiske sammensetninger inneholdende dem
GB1092886A (en) Preparation of a phenylalanine derivative
MA28192A1 (fr) NOUVELLE FORME CRISTALLINE ß DU SEL DE TERT-BUTYLAMINE DU PERINDOPRILL, SON PROCEDE DE PREPARATION ET LES COMPOSITIONS PHARMACEUTIQUES QUI LA CONTIENNENT.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: LES LABORATOIRES SERVIER, FR

B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20170530

Year of fee payment: 17

PBON Lapse due to non-payment of renewal fee

Effective date: 20180706